Pharmacokinetics and Tolerability of Nasal Versus Intravenous Midazolam in Healthy Dutch Volunteers: A Single-Dose, Randomized-Sequence, Open-Label, 2-Period Crossover Pilot Study

Nicole M. L. Veldhorst-Janssen, Audrey A. A. Fiddelers, Paul-Hugo M. van der Kuy, H. Maurice S. Theunissen, Marc C. T. F. M. de Krom, Cees Neef, Marco A. E. Marcus

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2022-2028
JournalClinical Therapeutics
Volume33
Issue number12
DOIs
Publication statusPublished - Dec 2011

Keywords

  • intranasal
  • midazolam
  • pharmacokinetics
  • pilot study

Cite this

Veldhorst-Janssen, N. M. L., Fiddelers, A. A. A., van der Kuy, P-H. M., Theunissen, H. M. S., de Krom, M. C. T. F. M., Neef, C., & Marcus, M. A. E. (2011). Pharmacokinetics and Tolerability of Nasal Versus Intravenous Midazolam in Healthy Dutch Volunteers: A Single-Dose, Randomized-Sequence, Open-Label, 2-Period Crossover Pilot Study. Clinical Therapeutics, 33(12), 2022-2028. https://doi.org/10.1016/j.clinthera.2011.10.012